Insider Profile
Escaravage, Jason
1
Companies Filed At
1
Open-Market Buys (2yr)
$587K
Buy Value (2yr, open-market)
Mar 10, 2026
Most Recent Trade
42
Credibility
Score
68%
Hit Rate
+1.9%
Avg 90d Return
+7.5%
Median 90d Return
25
Evaluated Trades
+16.5%
Best Trade
-19.8%
Worst Trade
Hit rate and returns are based on 25 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. This insider has a solid track record of profitable timing.
Cross-Company Track Record
THIN HISTORY
100%
Hit Rate · 90d
-3.4%
Median Alpha · 90d
1
Closed Buys Evaluated
0%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 1 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Buy 374 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Sell 573 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Sell 747 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Comp. Grant Buy 885 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Buy 3,036 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Sell 6,055 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Buy 2,662 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Sell 747 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 73 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Buy 255 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Buy 288 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Buy 374 58
Mar 10, 2026 $TRI
Thomson Reuters Corp
Exercise Sell 504 58
Mar 04, 2026 $TRI
Thomson Reuters Corp
Comp. Grant Buy 8,079 58
Mar 04, 2026 $TRI
Thomson Reuters Corp
Comp. Grant Buy 4,040 58
Dec 31, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 73 58
Sep 30, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 55 58
Jun 30, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 43 58
Jun 30, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 51 $172.96 $9K 58
Jun 25, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 3 $196.42 $589 58
Jun 10, 2025 $TRI
Thomson Reuters Corp
Comp. Grant Buy 2,755 $192.66 $531K 58
Jun 10, 2025 $TRI
Thomson Reuters Corp
Comp. Grant Buy 1,159 58
Jun 10, 2025 $TRI
Thomson Reuters Corp
Comp. Grant Buy 580 58
May 02, 2025 $TRI
Thomson Reuters Corp
Open Market Buy 3,226 $182.00 $587K 58
Mar 31, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 85 $146.86 $12K 58
Mar 19, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 3 $170.83 $512 58
Mar 13, 2025 $TRI
Thomson Reuters Corp
Exercise Buy 3,032 $173.74 $527K 58
Mar 13, 2025 $TRI
Thomson Reuters Corp
Exercise Buy 6,117 58
Mar 13, 2025 $TRI
Thomson Reuters Corp
Buyback Buy 35 58
Mar 10, 2025 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 42 $173.74 $7K 58
Dec 10, 2024 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 49 $170.14 $8K 58
Nov 10, 2024 $TRI
Thomson Reuters Corp
Exercise Sell 390 58
Nov 10, 2024 $TRI
Thomson Reuters Corp
Exercise Buy 194 58
Sep 10, 2024 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 51 $171.45 $9K 58
Jun 10, 2024 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 48 $170.74 $8K 58
Mar 06, 2024 $TRI
Thomson Reuters Corp
Comp. Grant Buy 7,310 $156.94 $1.1M 58
Mar 06, 2024 $TRI
Thomson Reuters Corp
Comp. Grant Buy 1,673 58
Mar 06, 2024 $TRI
Thomson Reuters Corp
Comp. Grant Buy 3,346 58
Dec 15, 2023 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 62 $138.85 $9K 58
Nov 10, 2023 $TRI
Thomson Reuters Corp
Exercise Sell 379 58
Nov 10, 2023 $TRI
Thomson Reuters Corp
Exercise Buy 189 58
Sep 15, 2023 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 70 $129.90 $9K 58
Jun 15, 2023 $TRI
Thomson Reuters Corp
Plan / DRIP Buy 110 $128.38 $14K 58
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.